Abstract

Background

Cholestasis in extremely premature infants (EPI) constitutes a nutritional challenge and maltodextrins have been reported as a possible strategy for hypoglycaemia. We aim to describe the nutritional management of an EPI with non-syndromic bile duct paucity (NSBDP) and feeding intolerance.

Case presentation

A patient, born at 27 weeks of gestational age, presented cholestatic jaundice at 20 days of life with a clinical picture of NSBDP. Patient’s growth was insufficient with formula rich in medium-chain triglyceride (MCT) and branched-chain amino acids (BCAA). Due to frequent fasting hypoglicemic episodes, maltodextrins supplements were provided. He subsequently presented severe abdominal distension and painful crises, which required hospital admission and withdrawal of maltodextrins. Hypercaloric extensively hydrolysed formula provided weight gain, glycemic control, and parallel improvement in cholestasis.

Conclusions

Our case suggests caution with the use of maltodextrins in infants, especially if premature. Commercial preparations for hepatopatic patients contain higher concentrations of MCTs and BCAAs, but personalized strategies must be tailored to each patient.

Details

Title
Non-syndromic bile duct paucity and non-IgE cow’s milk allergy: a case report of challenging nutritional management and maltodextrin intolerance
Author
Degrassi, Irene; Pascuzzi, Martina Chiara; Enza D’Auria; Fiori, Laura; Dilillo, Dario; Lista, Gianluca; Castoldi, Francesca Maria; Cavigioli, Francesco; Bosetti, Alessandra; Pellegrinelli, Alessandro; Zuccotti, Gian Vincenzo; Verduci, Elvira
Pages
1-6
Section
Case report
Publication year
2022
Publication date
2022
Publisher
BioMed Central
ISSN
17208424
e-ISSN
18247288
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2715358424
Copyright
© 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.